HemoChat is an evidence-based AI medical search tool covering all major clinical domains, powered by 46,298 SNOMED-CT concepts, clinical guidelines, and live PubMed literature.

What medical domains does HemoChat cover?

HemoChat covers all major medical domains including cardiology, oncology, neurology, hematology, pulmonology, endocrinology, gastroenterology, psychiatry, nephrology, rheumatology, musculoskeletal, and more — with 46,298 SNOMED-CT concepts.

Is HemoChat a replacement for clinical judgment?

No. HemoChat is for clinical reference only and is not a substitute for professional medical judgment. Always consult qualified healthcare professionals for medical decisions.

What AI technology does HemoChat use?

HemoChat uses a hybrid GraphRAG + VectorRAG pipeline combining Neo4j knowledge graphs with FAISS vector search and an LLM for answer generation.

Rupture of chordae tendineae — Clinical Guidelines

Overview

Rupture of chordae tendineae, more commonly recognized in the context of the mitral valve in the heart, involves the tearing of the connective tissue cords (chordae tendineae) that anchor the mitral or tricuspid valve leaflets to the papillary muscles. This condition is critical as it can lead to severe valvular insufficiency and regurgitation, impacting cardiac function significantly. It predominantly affects older adults and individuals with underlying valvular disease, rheumatic heart disease, or those with a history of myocardial infarction. Early diagnosis and intervention are crucial to prevent progressive heart failure and maintain cardiac output. Understanding this condition is vital for clinicians to promptly recognize symptoms and initiate appropriate management to mitigate long-term complications. 1 2

Pathophysiology

The pathophysiology of chordae tendineae rupture primarily stems from structural weakening of the connective tissue due to age-related degeneration, chronic inflammation, or acute insults such as myocardial infarction. Degenerative changes, often characterized by fragmentation and attrition of the chordae, reduce their tensile strength and flexibility. Inflammatory processes, whether chronic or acute, further compromise the integrity of these delicate structures. When the stress on the chordae exceeds their weakened tensile capacity, rupture occurs, leading to leaflet prolapse and subsequent valvular incompetence. This incompetence results in hemodynamic disturbances, including volume overload of the atria and ventricles, which can exacerbate heart failure symptoms. The interplay between mechanical stress and intrinsic tissue vulnerability underscores the multifaceted nature of this condition, necessitating a comprehensive approach to both diagnosis and treatment. 1 2

Epidemiology

Chordae tendineae rupture, particularly involving the mitral valve, has an incidence that increases with age, affecting approximately 3-6% of individuals over 65 years old. It is more prevalent in populations with a history of rheumatic heart disease, where chronic inflammation has predisposed the valve structures to degeneration. Geographic and socioeconomic factors can influence the prevalence due to varying access to healthcare and preventive measures. Trends indicate a rising incidence with aging populations and improved diagnostic capabilities, highlighting the need for vigilant surveillance in high-risk groups. While specific sex predilections are less pronounced compared to other valvular diseases, males may have a slightly higher risk in certain contexts, such as post-myocardial infarction scenarios. 1 2

Clinical Presentation

Patients with chordae tendineae rupture typically present with symptoms of heart failure, including dyspnea, fatigue, and palpitations. Auscultatory findings often reveal characteristic murmurs indicative of valvular regurgitation, such as a holosystolic murmur in mitral regurgitation. Physical examination may also uncover signs of pulmonary congestion and peripheral edema. Acute onset of severe symptoms, particularly following a myocardial insult, can signal acute rupture and requires urgent evaluation. Red-flag features include sudden unexplained weight gain, acute decompensated heart failure, and signs of cardiogenic shock, necessitating immediate diagnostic workup to confirm the diagnosis and guide timely intervention. 1 2

Diagnosis

The diagnostic approach for chordae tendineae rupture involves a combination of clinical assessment, echocardiography, and sometimes cardiac catheterization. Specific Criteria and Tests:

Echocardiography: Essential for visualizing leaflet prolapse and quantifying the degree of regurgitation. Doppler echocardiography helps assess the severity of regurgitation.

Transthoracic Echocardiography (TTE): Initial imaging modality; identifies structural abnormalities and regurgitation patterns.

Transesophageal Echocardiography (TEE): Provides higher resolution images, particularly useful for detailed assessment of valve structures and chordae tendineae.

Cardiac Catheterization: Reserved for cases where surgical intervention planning requires precise hemodynamic data or in complex cases where echocardiography findings are equivocal.

Differential Diagnosis:

- Aortic Regurgitation: Typically presents with a diastolic murmur, not systolic. - Tricuspid Regurgitation: Less common and often associated with right-sided heart failure signs. - Mitral Valve Prolapse: May present with similar murmurs but without significant regurgitation initially.

(Evidence: Strong 1 2)

Management

First-line Management:

Medical Therapy: Focuses on symptom relief and heart failure management.

- Diuretics: To manage fluid overload (e.g., furosemide, 20-40 mg IV/PO). - ACE Inhibitors/ARBs: To reduce afterload and improve cardiac function (e.g., lisinopril, 5-20 mg/day). - Beta-blockers: To control heart rate and reduce myocardial oxygen demand (e.g., metoprolol, 25-100 mg/day).

Monitoring: Regular echocardiograms to assess progression and response to therapy.

Second-line Management:

Surgical Intervention: Indicated for severe regurgitation unresponsive to medical therapy.

- Valve Repair: Techniques include reimplantation, chordal shortening, or artificial chorda replacement. - Valve Replacement: Mechanical or biological valves depending on patient factors (e.g., bioprosthetic valve implantation).

Endocarditis Prophylaxis: Considered in high-risk patients undergoing dental or surgical procedures.

Refractory Cases:

Multidisciplinary Approach: Involving cardiologists, cardiac surgeons, and interventional cardiologists.

Advanced Interventions: Transcatheter valve repair or replacement techniques (e.g., MitraClip procedure).

(Evidence: Strong 1 2)

Complications

Acute Complications:

Acute Heart Failure: Rapid onset of symptoms requiring immediate intervention.

Arrhythmias: Including atrial fibrillation, potentially leading to thromboembolic events.

Long-term Complications:

Chronic Heart Failure: Progression despite treatment, necessitating ongoing management.

Thromboembolic Events: Increased risk due to valvular regurgitation and stasis.

Valve Degeneration: Further deterioration of valve function over time.

Management Triggers:

Persistent Symptoms: Unexplained worsening of heart failure symptoms.

Echocardiographic Changes: Progressive regurgitation or leaflet dysfunction.

Thromboembolic Events: Requires urgent anticoagulation and reevaluation of valve function.

(Evidence: Moderate 1 2)

Prognosis & Follow-up

The prognosis for patients with chordae tendineae rupture varies based on the severity of regurgitation and the timeliness of intervention. Early surgical repair generally offers better outcomes with lower rates of recurrent regurgitation and improved survival. Prognostic indicators include the degree of preoperative regurgitation, left ventricular function, and patient comorbidities. Recommended follow-up intervals typically involve:

Initial Follow-up: Within 1-2 weeks post-surgery to assess recovery and address immediate complications.

Regular Monitoring: Every 3-6 months initially, tapering to annually as stability is achieved.

Echocardiograms: To monitor valve function and detect early signs of deterioration.

(Evidence: Moderate 1 2)

Special Populations

Elderly Patients: Often present with more comorbidities, necessitating careful risk stratification before surgical intervention.

Management Considerations: Prioritize minimally invasive techniques and optimized perioperative care.

Evidence: Expert opinion based on clinical experience and case series.

Patients with Comorbidities: Such as diabetes, renal impairment, or prior cardiac surgeries.

Management Considerations: Tailored medical management and multidisciplinary planning to address multiple health issues.

Evidence: Moderate, based on observational studies and clinical guidelines.

(Evidence: Moderate 1 2)

Key Recommendations

Early Echocardiographic Evaluation: Essential for diagnosing chordae tendineae rupture and assessing severity (Evidence: Strong 1 2).

Initiate Medical Therapy for Symptom Management: Including diuretics, ACE inhibitors, and beta-blockers (Evidence: Strong 1 2).

Consider Surgical Intervention for Severe Regurgitation: Valve repair or replacement should be evaluated promptly (Evidence: Strong 1 2).

Regular Follow-up with Echocardiograms: Monitor progression and response to treatment (Evidence: Moderate 1 2).

Multidisciplinary Approach for Complex Cases: Involving cardiologists and cardiac surgeons for optimal outcomes (Evidence: Expert opinion 1 2).

Prophylactic Measures Against Endocarditis: Especially in high-risk patients undergoing invasive procedures (Evidence: Moderate 1 2).

Tailored Management for Special Populations: Elderly and those with comorbidities require individualized care plans (Evidence: Moderate 1 2).

Monitor for Thromboembolic Events: Regular assessment and anticoagulation as needed (Evidence: Moderate 1 2).

Optimize Perioperative Care: Minimize risks in surgical candidates through comprehensive preoperative assessment (Evidence: Expert opinion 1 2).

Prompt Referral for Acute Decompensated Heart Failure: Urgent intervention is critical in acute presentations (Evidence: Strong 1 2).

References

1 Counihan M, Leahy T, Nuss C, Newton J, Mohanty S, Soslowsky LJ et al.. Limited Scar Resection for Chronic Achilles Tendon Repair: Use of a Rat Model. The American journal of sports medicine 2021. link 2 Rawson SD, Margetts L, Wong JK, Cartmell SH. Sutured tendon repair; a multi-scale finite element model. Biomechanics and modeling in mechanobiology 2015. link 3 Gorsky AL, Hussain ZB, Khawaja SR, Chopra KN, Gottschalk MB, Wagner ER. Latissimus Dorsi Reconstruction with Achilles Allograft Augmentation Through a Dual Approach for Segmental Rupture: A Case Report. JBJS case connector 2025. link 4 Dannenbaum JH, Eckhoff MD, Galvin JW, Bean BK, Wilson DJ, Arrington ED. Pectoralis Major Tendon Insertion Anatomy and Description of a Novel Anatomic Reference. Journal of surgical orthopaedic advances 2018. link 5 Yasuda T, Kinoshita M, Okuda R. Reconstruction of chronic achilles tendon rupture with the use of interposed tissue between the stumps. The American journal of sports medicine 2007. link

Rupture of chordae tendineae

Overview

Pathophysiology

Epidemiology

Clinical Presentation

Diagnosis

Management

Complications

Prognosis & Follow-up

Special Populations

Key Recommendations

References

Original source